Article info

PDF

Original article
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer

Authors

  1. Correspondence to Professor Yon Hui Kim, New Experimental Therapeutics Branch, National Cancer Center of Korea, Ilsan, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; yhkim{at}ncc.re.kr; Professor Han Liang, The University of Texas MD Anderson Cancer Center, Houston TX, 77030, USA; hliang1@mdanderson.org; and Professor Taesung Park, Seoul National University, Kwanak-ro, Kwanak-gu Seoul, 151-742, Republic of Korea; tspark@stats.snu.ac.kr
View Full Text

Citation

Chang HR, Nam S, Kook M, et al
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer

Publication history

  • Received June 26, 2014
  • Revised October 10, 2014
  • Accepted October 25, 2014
  • First published November 19, 2014.
Online issue publication 
December 08, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.